The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale
Open accessAbstract
Purpose: The platinum chemotherapy agents cisplatin and carboplatin are widely used in the treatment of adult and pediatric cancers. Cisplatin causes hearing loss in at least 60% of pediatric patients. Reducing cisplatin and high-dose carboplatin ototoxicity without reducing efficacy is important. Patients and Methods: This review summarizes recommendations made at the 42nd Congress of the International Society of Pediatric Oncology (SIOP) in Boston, October 21-24, 2010, reflecting input from international basic scientists, pediatric oncologists, otolaryngologists, oncology nurses, audiologists, and neurosurgeons to develop and advance research and clinical trials for otoprotection. Results: Platinum initially impairs hearing in the high frequencies and progresses to lower frequencies with increasing cumulative dose. Genes involved in drug transport, metabolism, and DNA repair regulate platinum toxicities. Otoprotection can be achieved by acting on several these pathways and generally involves antioxidant thiol agents. Otoprotection is a strategy being explored to decrease hearing loss while maintaining dose intensity or allowing dose escalation, but it has the potential to interfere with tumoricidal effects. Route of administration and optimal timing relative to platinum therapy are critical issues. In addition, international standards for grading and comparing ototoxicity are essential to the success of prospective pediatric trials aimed at reducing platinum-induced hearing loss. Conclusion: Collaborative prospective basic and clinical trial research is needed to reduce the incidence of irreversible platinum-induced hearing loss, and optimize cancer control. Wide use of the new internationally agreed-on SIOP Boston ototoxicity scale in current and future otoprotection trials should help facilitate this goal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Replicating genotype–phenotype associations
NCI-NHGRI Working Group on Replication in Association Studies, Chanock, S. J., Manolio, T., Boehnke, M., Boerwinkle, E., Hunter, D. J., Thomas, G., Hirschhorn, J. N., Abecasis, G., Altshuler, D., et al. (2007) · Nature · doi:10.1038/447655a · Cited by 1,352
Prezant, T. R., Agapian, J. V., Bohlman, M. C., Bu, X., Öztas, S., Qiu, W.-Q., Arnos, K. S., Cortopassi, G. A., Jaber, L., Rotter, J. I., et al. (1993) · Nature Genetics · doi:10.1038/ng0793-289 · Cited by 1,196
Bess, F. H., Dodd-Murphy, J., & Parker, R. A. (1998) · Ear and Hearing · doi:10.1097/00003446-199810000-00001 · Cited by 847 · cited 1×
“High-frequency hearing loss in older children and adolescents has an impact on ease of listening and may negatively affect educational achievement and social-emotional development.(60) Learning in a classroom environment is highly dependent on hearing and listening.”
BackgroundPlatinum Resistance: The Role of DNA Repair Pathways
Martin, L. P., Hamilton, T. C., & Schilder, R. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2238 · Cited by 751
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
Review of the Comparative Pharmacology and Clinical Activity of Cisplatin and Carboplatin
Go, R. S., & Adjei, A. A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.409 · Cited by 697
Mechanisms of cisplatin-induced ototoxicity and prevention
Rybak, L. P., Whitworth, C. A., Mukherjea, D., & Ramkumar, V. (2007) · Hearing Research · doi:10.1016/j.heares.2006.09.015 · Cited by 563
Knight, K. R. G., Kraemer, D. F., & Neuwelt, E. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.00.5355 · Cited by 542
Self-citationHensley, M. L., Hagerty, K. L., Kewalramani, T., Green, D. M., Meropol, N. J., Wasserman, T. H., Cohen, G. I., Emami, B., Gradishar, W. J., Mitchell, R. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2627 · Cited by 540
Strategies to advance translational research into brain barriers
Neuwelt, E., Abbott, N. J., Abrey, L., Banks, W. A., Blakley, B., Davis, T., Engelhardt, B., Grammas, P., Nedergaard, M., Nutt, J., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70326-5 · Cited by 474
Self-citationShould Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?
Lawenda, B. D., Kelly, K. M., Ladas, E. J., Sagar, S. M., Vickers, A., & Blumberg, J. B. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn148 · Cited by 472
Nox3, a superoxide-generating nadph oxidase of the inner ear
Bánfi, B., Malgrange, B., Knisz, J., Steger, K., Dubois-Dauphin, M., & Krause, K.-H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403046200 · Cited by 467
Davis, J. M., Elfenbein, J., Schum, R., & Bentler, R. A. (1986) · Journal of Speech and Hearing Disorders · doi:10.1044/jshd.5101.53 · Cited by 412
Apoptosis by cisplatin requires p53 mediated p38α MAPK activation through ROS generation
Bragado, P., Armesilla, A., Silva, A., & Porras, A. (2007) · Apoptosis · doi:10.1007/s10495-007-0082-8 · Cited by 362
Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose
Li, Y., Womer, R. B., & Silber, J. H. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.009 · Cited by 358
the CPNDS Consortium, Ross, C. J. D., Katzov-Eckert, H., Dubé, M.-P., Brooks, B., Rassekh, S. R., Barhdadi, A., Feroz-Zada, Y., Visscher, H., Brown, A. M. K., et al. (2009) · Nature Genetics · doi:10.1038/ng.478 · Cited by 327
Self-citationZhou, W., Gurubhagavatula, S., Liu, G., Park, S., Neuberg, D. S., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0247 · Cited by 291
Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways
Park, M. S., De Leon, M., & Devarajan, P. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134858 · Cited by 279
Finitzo-Hieber, T., & Tillman, T. W. (1978) · Journal of Speech and Hearing Research · doi:10.1044/jshr.2103.440 · Cited by 278
Kopke, R. D., Liu, W., Gabaizadeh, R., Jacono, A., Feghali, J. G., Spray, D. C., Garcia, P., Steinman, H., Malgrange, B., Ruben, R. J., et al. (1997) · PubMed · Cited by 266
d-Methionine provides excellent protection from cisplatin ototoxicity in the rat
Campbell, K. C. M., Rybak, L. P., Meech, R. P., & Hughes, L. (1996) · Hearing Research · doi:10.1016/s0378-5955(96)00152-9 · Cited by 240
Self-citationSuperiority, equivalence, and non-inferiority trials.
Lesaffre, E. M. E. H. (2008) · PubMed · Cited by 225
Dickey, D. T., Wu, Y. J., Muldoon, L. L., & Neuwelt, E. A. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087601 · Cited by 219
Self-citationPrevention of noise- and drug-induced hearing loss with d-methionine
Campbell, K. C. M., Meech, R. P., Klemens, J. J., Gerberi, M. T., Dyrstad, S. S. W., Larsen, D. L., Mitchell, D. L., El-Azizi, M., Verhulst, S. J., & Hughes, L. F. (2007) · Hearing Research · doi:10.1016/j.heares.2006.11.012 · Cited by 213
Self-citationGurney, J. G., Tersak, J. M., Ness, K. K., Landier, W., Matthay, K. K., & Schmidt, M. L. (2007) · Pediatrics · doi:10.1542/peds.2007-0178 · Cited by 201
Effect of protective agents against cisplatin ototoxicity.
Rybak, L. P., Husain, K. M., Morris, C., Whitworth, C. A., & Somani, S. M. (2000) · PubMed · Cited by 200
Oldenburg, J., Kraggerud, S. M., Cvancarova, M., Lothe, R. A., & Fossa, S. D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9599 · Cited by 197
Blood-neural barrier: its diversity and coordinated cell-to-cell communication
Choi, Y.-K., & Kim, K. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.5.345 · Cited by 185
Speech Recognition in Noise by Children with Minimal Degrees of Sensorineural Hearing loss
Crandell, C. C. (1993) · Ear and Hearing · doi:10.1097/00003446-199306000-00008 · Cited by 178
Role of the Copper Transporter, CTR1, in Platinum-Induced Ototoxicity
More, S. S., Akil, O., Ianculescu, A. G., Geier, E. G., Lustig, L. R., & Giacomini, K. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-10.2010 · Cited by 176
Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity
Rybak, L. P., Whitworth, C., & Somani, S. (1999) · The Laryngoscope · doi:10.1097/00005537-199911000-00003 · Cited by 169
Lynch, E. D., Gu, R., Pierce, C., & Kil, J. (2005) · Hearing Research · doi:10.1016/j.heares.2004.08.002 · Cited by 167
Caspase Activation in Hair Cells of the Mouse Utricle Exposed to Neomycin
Cunningham, L. L., Cheng, A. G., & Rubel, E. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08532.2002 · Cited by 159
Fouladi, M., Chintagumpala, M., Ashley, D. M., Kellie, S. J., Gururangan, S., Hassall, T., Gronewold, L., Stewart, C. F., Wallace, D., Broniscer, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3974 · Cited by 149
Cisplatin Ototoxicity: Involvement of Iron and Enhanced Formation of Superoxide Anion Radicals
Dehne, N., Lautermann, J., Petrat, F. M., Rauen, U., & de GROOT, H. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9171 · Cited by 148
Mukherjea, D., Jajoo, S., Whitworth, C. A., Bunch, J. R., Turner, J. G., Rybak, L. P., & Ramkumar, V. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1307-08.2008 · Cited by 147
Casano, R. A. M. S., Johnson, D., Bykhovskaya, Y., Torricelli, F., Bigozzi, M., & Fischel‐Ghodsian, N. (1999) · American Journal of Otolaryngology · doi:10.1016/s0196-0709(99)90062-5 · Cited by 147
Caronia, D., Patiño‐García, A., Milne, R. L., Zalacaín, M., Pita, G., Alonso, M. R., Moreno, L. T., Sierrasesúmaga-Ariznabarreta, L., Benitez, J. J., & González‐Neira, A. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.19 · Cited by 144
Peters, U., Preisler-Adams, S., Hebeisen, A., Hahn, M., Seifert, E., Lanvers, C., Heinecke, A., Horst, J., Jürgens, H., & Lamprecht-Dinnesen, A. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200009000-00007 · Cited by 143
Cisplatin-Induced Ototoxicity: Effect of Intratympanic Dexamethasone Injections
Hill, G. W., Morest, D. K., & Parham, K. (2008) · Otology & Neurotology · doi:10.1097/mao.0b013e31818599d5 · Cited by 143
Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model
Dickey, D. T., Muldoon, L. L., Kraemer, D. F., & Neuwelt, E. A. (2004) · Hearing Research · doi:10.1016/j.heares.2004.02.007 · Cited by 130
Self-citationPolymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients
Suk, R. N., Gurubhagavatula, S., Park, S., Zhou, W., Li, S., Lynch, T. J., Wain, J. C., Neuberg, D. S., Liu, G., & Christiani, D. C. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1953 · Cited by 128
The anticancer drug cisplatin induces an intrinsic apoptotic pathway inside the inner ear
García‐Berrocal, J. R., Nevado, J. B., Ramírez‐Camacho, R., Fernández, R. S., González-García, J. Á., Sánchez‐Rodríguez, C., Cantos, B., España, P., Verdaguer, J. M., & Cabezas, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707405 · Cited by 121
Dickey, D. T., Muldoon, L. L., Doolittle, N. D., Peterson, D. R., Kraemer, D. F., & Neuwelt, E. A. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-007-0597-2 · Cited by 120
Self-citationMegalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin
Riedemann, L., Lanvers, C., Deuster, D., Peters, U., Boos, J., Jürgens, H., & Zehnhoff‐Dinnesen, A. A. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500455 · Cited by 119
Hofstetter, P., Ding, D., Powers, N. L., & Salvi, R. (1997) · Hearing Research · doi:10.1016/s0378-5955(97)00123-8 · Cited by 113
Partial reversibility of cisplatin nephrotoxicity in children
Brock, P. R., Koliouskas, D. E., Barratt, T. M., Yeomans, E. C., & Pritchard, J. (1991) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)83372-4 · Cited by 111
Self-citationRybak, L. P. (1999) · Toxicological Sciences · doi:10.1093/toxsci/47.2.195 · Cited by 105
Doolittle, N. D., Muldoon, L. L., Brummett, R. E., Tyson, R. M., Lacy, C. A., Bubalo, J. S., Kraemer, D. F., Heinrich, M. C., Henry, J. A., & Neuwelt, E. A. (2001) · PubMed · Cited by 100
Self-citationKatzenstein, H. M., Chang, K. W., Krailo, M., Chen, Z., Finegold, M. J., Rowland, J., Reynolds, M., Pappo, A. S., London, W. B., & Malogolowkin, M. H. (2009) · Cancer · doi:10.1002/cncr.24667 · Cited by 96
Self-citationThomas, J. P., Lautermann, J., Liedert, B., Seiler, F., & Thomale, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022244 · Cited by 90
Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage
Sergi, B., Ferraresi, A., Troiani, D., Paludetti, G., & Fetoni, A. R. (2003) · Hearing Research · doi:10.1016/s0378-5955(03)00142-4 · Cited by 86
Cheng, A. G.-L., Cunningham, L. L., & Rubel, E. W. (2003) · Journal of the Association for Research in Otolaryngology · doi:10.1007/s10162-002-3016-8 · Cited by 86
Ototoxicity in children treated for osteosarcoma
Lewis, M., DuBois, S. G., Fligor, B. J., Li, X., Goorin, A. M., & Grier, H. E. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21875 · Cited by 83
Self-citationOtotoxic drugs: Difference in sensitivity between mice and guinea pigs
Poirrier, A., den Ackerveken, P. V., Kim, T. S., Vandenbosch, R., Nguyen, L., Lefebvre, P. P., & Malgrange, B. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.12.003 · Cited by 81
Protective effects of α-tocopherol and tiopronin against cisplatin-induced ototoxicity
Fetoni, A. R., Sergi, B., Ferraresi, A., Paludetti, G., & Troiani, D. (2004) · Acta Oto-Laryngologica · doi:10.1080/00016480410016559 · Cited by 75
Paksoy, M., Ayduran, E., Şanlı, A., Eken, M., Aydın, S., & Oktay, Z. A. (2010) · Medical Oncology · doi:10.1007/s12032-010-9477-4 · Cited by 73
Shord, S. S., Thompson, D. M., Krempl, G. A., & Hanigan, M. H. (2006) · Anti-Cancer Drugs · doi:10.1097/00001813-200602000-00013 · Cited by 73
Lynch, E. D., Gu, R., Pierce, C., & Kil, J. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200506000-00013 · Cited by 65
Harned, T. M., Kalous, O., Neuwelt, A. J., Loera, J., Ji, L., Iovine, P. M., Sposto, R., Neuwelt, E. A., & Reynolds, C. P. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2289 · Cited by 65
Self-citationImmunohistochemical detection of platinated DNA in the cochlea of cisplatin-treated guinea pigs
van Ruijven, M. W. M., de Groot, J. C. M. J., Hendriksen, F. G. J., & Smoorenburg, G. F. (2005) · Hearing Research · doi:10.1016/j.heares.2004.12.007 · Cited by 58
Neuwelt, E. A., Brummett, R. E., Remsen, L. G., Kroll, R. A., Pagel, M. A., McCormick, C. I., Guitjens, S. K., & Muldoon, L. L. (1996) · PubMed · Cited by 55
Self-citationNormal and Hearing-Impaired Word Recognition Scores for Monosyllabic Words in Quiet and Noise
Beattie, R. C., Barr, T., & Roup, C. M. (1997) · British Journal of Audiology · doi:10.3109/03005364000000018 · Cited by 53
Neuwelt, A. J., Wu, Y. J., Knap, N., Łosin, M., Neuwelt, E. A., Pagel, M. A., Warmann, S. W., Fuchs, J., Czauderna, P. S., & Woźniak, M. (2009) · Neoplasia · doi:10.1593/neo.09688 · Cited by 34
Self-citationPharmacogenomic can give children safer medicines
Impicciatore, M. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.4.366 · Cited by 13
Cited by
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
Robison, L. L., & Hudson, M. M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3634 · Cited by 857
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity
Karasawa, T., & Steyger, P. S. (2015) · Toxicology Letters · doi:10.1016/j.toxlet.2015.06.012 · Cited by 475
Self-citationSodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
Brock, P. R., Maibach, R., Childs, M., Rajput, K., Roebuck, D., Sullivan, M. J., Laithier, V., Ronghe, M., Dall’Igna, P., Hiyama, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801109 · Cited by 380
Self-citationFrisina, R. D., Wheeler, H. E., Fossa, S. D., Kerns, S. L., Fung, C., Sesso, H. D., Monahan, P. O., Feldman, D. R., Hamilton, R., Vaughn, D. J., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.8822 · Cited by 278
Drug‐induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies
Lanvers‐Kaminsky, C., Zehnhoff‐Dinnesen, A. A., Parfitt, R., & Ciarimboli, G. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.603 · Cited by 277
Metadata
- Authors
- Brock, P. R., Knight, K. R., Freyer, D. R., Campbell, K. C. M., Steyger, P. S., Blakley, B. W., Rassekh, S. R., Chang, K. W., Fligor, B. J., Rajput, K., Sullivan, M., & Neuwelt, E. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-07-01
- Volume
- 30
- Issue
- 19
- Pages
- 2408-2417
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2165126891
- Cited by
- 380
- References
- 67
- FWCI
- 13.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.